Stress-induced changes in LPS-induced pro-inflammatory cytokine production in chronic fatigue syndrome.
Gaab, Jens, Rohleder, Nicolas, Heitz, Vera et al. · Psychoneuroendocrinology · 2005 · DOI
Quick Summary
This study tested how ME/CFS patients' immune systems respond to stress compared to healthy people. Researchers gave both groups a stressful public speaking task, then exposed their blood samples to a bacterial substance to measure immune response. Unlike healthy controls whose immune response increased after stress, ME/CFS patients showed a decreased immune response, suggesting their bodies may not mobilize infection-fighting chemicals normally during stress.
Why It Matters
Understanding immune dysregulation in ME/CFS is critical for developing targeted treatments. This study challenges the hypothesis that ME/CFS involves exaggerated cytokine release during stress, instead suggesting a blunted or suppressed immune response—a finding that could reshape how researchers approach anti-inflammatory interventions and HPA axis therapies.
Observed Findings
CFS patients showed attenuated (decreased) LPS-stimulated IL-6 and TNF-α production in the 10-60 minutes following acute stress, opposite to the increased response in healthy controls.
Basal (resting) cytokine levels correlated significantly with fatigue severity in CFS patients for both IL-6 and TNF-α, and in controls for TNF-α only.
Cortisol and ACTH responses to the stressor were normal in CFS patients, indicating intact HPA axis reactivity despite abnormal immune response patterns.
Fatigue scores in CFS patients were associated with integrated LPS-induced cytokine levels, though this association was primarily driven by basal rather than stress-induced changes.
Inferred Conclusions
CFS is not characterized by exaggerated pro-inflammatory cytokine secretion in response to acute stress, contradicting prior hypotheses.
The attenuated cytokine response in CFS may reflect enhanced glucocorticoid sensitivity, reduced catecholaminergic responsiveness, or impaired intracellular immune signaling.
Basal immune activation, rather than stress-induced changes, is the stronger correlate of fatigue in ME/CFS patients.
HPA axis dysfunction does not fully explain the immune dysregulation observed in CFS, suggesting other intracellular mechanisms are involved.
Remaining Questions
What intracellular signaling mechanisms account for the attenuated cytokine response—are there defects in glucocorticoid receptor sensitivity, adrenergic receptor function, or NF-κB activation pathways?
What This Study Does Not Prove
This cross-sectional study does not prove causation—it cannot establish whether immune suppression causes fatigue or results from it. The findings are limited to acute laboratory stress and may not reflect how immune systems respond during prolonged, real-world stressors or post-exertional malaise. The sample size is relatively modest, limiting generalizability.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Do these acute laboratory stress findings extend to chronic, real-world stressors or post-exertional malaise scenarios where patients report symptom exacerbation?
Is the inverse immune response pattern specific to LPS stimulation, or does it generalize to other immune challenges (viral antigens, mitogen stimulation)?
Could medications, prior infections, or other confounders be responsible for the attenuated immune response, and were these variables controlled for in the analysis?